Skip to main content
. 2019 Aug 26;18:1533033819869949. doi: 10.1177/1533033819869949

Figure 6.

Figure 6.

The expression level of (A) immune stimulators and (B) immune inhibitors in nontumor and GBM samples. Statistical significance was determined by the Wilcoxcon test (***P < .001, **P < .01, *P < .05). GBM indicates glioblastoma; TCGA, The Cancer Genome Atlas.